Clearmind Medicine (Clearmind Medicine) Common Stock : $22.52 Mil (As of Jan. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Clearmind Medicine Common Stock?

Clearmind Medicine's quarterly common stock increased from Jul. 2023 ($11.27 Mil) to Oct. 2023 ($12.39 Mil) and increased from Oct. 2023 ($12.39 Mil) to Jan. 2024 ($22.52 Mil).

Clearmind Medicine's annual common stock declined from Oct. 2021 ($6.38 Mil) to Oct. 2022 ($4.93 Mil) but then increased from Oct. 2022 ($4.93 Mil) to Oct. 2023 ($12.39 Mil).

Clearmind Medicine Common Stock Historical Data

The historical data trend for Clearmind Medicine's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clearmind Medicine Common Stock Chart

Clearmind Medicine Annual Data

Trend

Oct17

Oct18

Oct19

Oct20

Oct21

Oct22

Oct23

Common Stock

Get a 7-Day Free Trial

0.22

0.67

6.38

4.93

12.39

Clearmind Medicine Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Common Stock	Get a 7-Day Free Trial															13.22	10.81	11.27	12.39	22.52

Clearmind Medicine Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Clearmind Medicine (Clearmind Medicine) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clearmind Medicine Inc (NAS:CMND) » Definitions » Common Stock

Comparable Companies

Traded in Other Exchanges

CWY0:Germany CWY0:Germany CMND:Canada

Address

101-1220 West 6th Avenue, Vancouver, BC, CAN, V6H 1A5

Website

https://www.clearmindmedicine.com

Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.